Subcutaneous cardioverter defibrillator has longer time to therapy but is less cardiotoxic than transvenous cardioverter defibrillator. Study carried out in a preclinical porcine model

  • Rodrigue Garcia, Sofiane Inal, Frederic Favreau, Christophe Jayle, Thierry Hauet, Patrick Bruneval, Thomas Kerforne, Jamil Hajj-Chahine, Bruno Degand
  • EP Europace, April 2017, Oxford University Press (OUP)
  • DOI: 10.1093/europace/eux074

The authors haven't yet claimed this publication.

Read Publication